Navigating Drug Pricing Complexities

This chapter delves into the intricate issues surrounding drug pricing and negotiation in the U.S. healthcare system, highlighting the conflict between pharmaceutical companies and insurance providers, as well as the implications for drug accessibility and healthcare spending compared to other countries.